Mirae Asset Global Etfs Holdings Ltd. Vaxcyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 57,256 shares of PCVX stock, worth $5.93 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,256Holding current value
$5.93 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
299Shares Held
110MCall Options Held
246KPut Options Held
118K-
Black Rock Inc. New York, NY9.94MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.02 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$919 Million0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$850 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$476 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.15B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...